Invictus RG’s STAAR Surgical STAA Stock Holding History

Invictus RG’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,496	Closed	-$552K	–	126
2018 Q3	$552K	Buy	+11,496	New	+$471K	0.42%	54

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invictus RG's STAA Position: Q4 2018 in Review

Invictus RG sold out of STAAR Surgical (STAA) in Q4 2018, closing a stake of 11,496 shares — an estimated $552K sold.

Invictus RG first reported a position in STAA in Q3 2018 and held it in 1 quarter. The position peaked at $552K in Q3 2018. 181 funds tracked by Wall St. Rank hold STAA as of Q4 2018.

Invictus RG reported no remaining STAAR Surgical position as of Q4 2018 after selling out during the quarter.
Invictus RG sold 11,496 STAAR Surgical shares in Q4 2018, an estimated $552K.
Invictus RG first reported a position in STAAR Surgical in Q3 2018 and held it in 1 quarter.
Invictus RG's STAAR Surgical position peaked at $552K in Q3 2018.
181 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.